ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,548, issued on Sept. 23, was assigned to Sanofi (Paris).
"Implantable glucose monitor" was invented by Thomas Klemm (Frankfurt am Main, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "Implantable device for measuring the glucose concentration of a body fluid when implanted, the implantable device comprising a glucose measurement unit, the glucose measurement unit comprising a first light source configured to emit light towards a light transmissive part of a housing of the device and a first optical sensor configured to detect light returned through the light transmissive part from the first light source, and output a first electrical signal ...